Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_03093
Species: Mus musculus
Position : chr17:35502632-35504632
Year: 2014
Title: Comparison of TALE designer transcription factors and the CRISPR/dCas9 in regulation of gene expression by targeting enhancers.
Genome Build: mm10
Enhancer Type: Enhancer
Condition: Normal
PMID:  25223790
Cell Source: Embryonic Stem Cell
Experiment Type: Enhancer activity assay; TF-binding/chromatin assay; Endogenous enhancer perturbation
High Throughput Method: ChIP-seq
Low Throughput Method: Luciferase reporter assay; Reporter assay; CRISPR-Cas9 targeted editing/deletion; ChIP-qPCR/ChIP; RT-qPCR/qPCR
About Target Gene
Target gene : NA
About TF
TF name : Sox2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
Sox2 Deactivation of the beta-catenin transactivating complex reactome 42
Sox2 POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation reactome 13
Sox2 POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation reactome 10
Sox2 Transcriptional regulation of pluripotent stem cells reactome 28
Sox2 Hs_Endoderm_Differentiation_WP2853_88152 wikipathways 62
Sox2 Hs_Dopaminergic_Neurogenesis_WP2855_87239 wikipathways 19
Sox2 Hs_Wnt_Signaling_Pathway_and_Pluripotency_WP399_90291 wikipathways 12
Sox2 Hs_Mesodermal_Commitment_Pathway_WP2857_87780 wikipathways 47
Sox2 Hs_Ectoderm_Differentiation_WP2858_89329 wikipathways 56
Enhancer Associated Network
Overlapping Enhancers (mm10) 7 found
Enhancer ID Position Tissue Cell Disease
E_01460 chr17:35499359-35507923 NA NA NA
E_01937 chr17:35501113-35507015 NA NA NA
E_01871 chr17:35501272-35506872 NA NA NA
E_03090 chr17:35502632-35504632 NA NA NA
E_03091 chr17:35502632-35504632 NA NA NA
E_03092 chr17:35502632-35504632 NA NA NA
E_01517 chr17:35503912-35504118 embryo embryonic stem cell NA
Expression of Target Genes for the Enhancer